Skip to main content

Phagekines: Screening Binding Properties and Biological Activity of Functional Cytokines Displayed on Phages

  • Protocol
  • First Online:
Phage Display

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1701))

Abstract

The current chapter focuses on the use of filamentous phages to display, modify, and characterize cytokines, which are proteins belonging to a versatile group of essential mediators involved in cell-cell communication. Cytokines exhibit a considerable diversity, both in functions and in structural features underlying their biological effects. A broad variety of cytokines have been successfully displayed on phages, allowing the high-throughput study of their binding properties and biological activities and the discovery of novel therapeutics through directed evolution. The technical singularities and some potential applications of cytokine phage display are illustrated here with the case of Interleukin-2, a prototypic member of the four-alpha-helix bundle cytokine family playing a pivotal role in the immune response and having a long history of therapeutic use.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Smith GP (1985) Filamentous fusion page: novel expression vectors that display cloned antigens on the virion surface. Science 228:1315–1317

    Article  CAS  PubMed  Google Scholar 

  2. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G (1991) By-passing immunization-human antibodies from V-gene libraries displayed on phage. J Mol Biol 222:581–597

    Article  CAS  PubMed  Google Scholar 

  3. Felici F, Castagnoli L, Musacchio A, Japelli R, Cesareni G (1991) Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J Mol Biol 222:301–310

    Article  CAS  PubMed  Google Scholar 

  4. Smith GP, Petrenko VA (1997) Phage display. Chem Rev 97:391–410

    Article  CAS  PubMed  Google Scholar 

  5. Klapper JA, Downey SG, Smith FO, Yang JC, Hughes MS, Kammula US, Sherry RM, Royal RE, Steinberg SM, Rosenberg S (2008) High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma: a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006. Cancer 113:293–301

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Koreth J, Phil D, Matsuoka K, Kim HT, Mc Donough SM, Bindra B, Alyea EP, Armand P, Cutler C, Ho VT, Treister NS, Bienfang DC, Prasad S, Tzachanis D, Joyce RM, Avigan DE, Antin JH, Ritz J, Soiffer RJ (2011) Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med 365:2055–2066

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Rao BM, Driver L, Lauffenburger DA, Wittrup KD (2005) High-affinity CD25-binding IL-2 mutants potently stimulate persistent T cell growth. Biochemistry 44:10696–10701

    Article  CAS  PubMed  Google Scholar 

  8. Levin AM, Bates DL, Ring AM, Krieg C, Lin JT, Su L, Moraga I, Raeber ME, Bowman GR, Novick P, Pande VS, Fathman CG, Boyman O, Garcia KC (2012) Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’. Nature 484:529–533

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Carmenate T, Pacios A, Enamorado M, Moreno E, Garcia-Martinez K, Fuente D, Leon K (2013) Human Interleukin-2 mutein with higher antitumor efficacy than wild type IL-2. J Immunol 190:6230–6238

    Article  CAS  PubMed  Google Scholar 

  10. Mitra S, Ring AM, Amarnath S, Spangler JB, Li P, Ju W, Fischer S, Oh J, Spolski R, Weiskopf K, Kohrt H, Foley JE, Rajagopalan S, Long EO, Fowler DH, Waldmann TA, Garcia KC, Leonard WJ (2015) Interleukin-2 activity can be fine tuned with engineered receptor signaling clamps. Immunity 42:826–838

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Hartley O, Dorgham K, Perez-Bercoff D, Cerini F, Heimann A, Gaertner H, Offord RE, Pancino G, Debre P, Gorochov G (2003) Human Immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines. J Virol 77:6637–6644

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Gram H, Strittmatter U, Lorenz M, Gluck D, Zenke G (1993) Phage display as a rapid gene expression system: production of bioactive cytokine-phage and generation of neutralizing monoclonal antibodies. J Immunol Methods 161:169–176

    Article  CAS  PubMed  Google Scholar 

  13. Kalie E, Jaitin DA, Abramovich R, Schreiber G (2007) An interferon alpha-2 mutant optimized by phage display for IFNAR1 binding confers specifically enhanced antitumor activities. J Biol Chem 282:11602–11611

    Article  CAS  PubMed  Google Scholar 

  14. Shibata H, Yoshioka Y, Ikemizu S, Kobayashi K, Yamamoto Y, Mukai Y, Okamoto T, Taniai M, Kawamura M, Abe Y, Nakagawa S, Hayakawa T, Nagata S, Yamagata Y, Mayumi T, Kamada H, Tsutsumi Y (2004) Functionalization of tumor necrosis factor-alpha using phage display technique and PEGylation improves its antitumor therapeutic window. Clin Cancer Res 10:8293–8300

    Article  CAS  PubMed  Google Scholar 

  15. Buchli PJ, Wu Z, Ciardelli TL (1997) The functional display of interleukin-2 on filamentous phage. Arch Biochem Biophys 339:79–84

    Article  CAS  PubMed  Google Scholar 

  16. Vispo NS, Callejo M, Ojalvo AG, Santos A, Chinea G, Gavilondo JV, Araña MJ (1997) Displaying human interleukin-2 on the surface of bacteriophage. Immunotechnology 3:185–193

    Article  CAS  PubMed  Google Scholar 

  17. Kunkel TA (1985) Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A 82:488–492

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Rojas G, Pupo A, Leon K, Avellanet J, Carmenate T, Sidhu S (2013) Deciphering the molecular bases of the biological effects of antibodies against Interleukin-2: a versatile platform for fine epitope mapping. Immunobiology 218:105–113

    Article  CAS  PubMed  Google Scholar 

  19. Rojas G, Infante YC, Pupo A, Carmenate T (2014) Fine specificity of antibodies against Interleukin-2 explains their paradoxical immunomodulatory effects. mAbs 6:273–285

    Article  PubMed  Google Scholar 

  20. Rojas G, Carmenate T, Leon K (2015) Molecular dissection of the interactions of an antitumor Interleukin-2-derived mutein on a phage display-based platform. J Mol Recognit 28:261–268

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

G. Rojas is partially supported by a Georg Forster research fellowship awarded by the Alexander von Humboldt Foundation, Germany.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gertrudis Rojas .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media LLC

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Rojas, G., Carmenate, T. (2018). Phagekines: Screening Binding Properties and Biological Activity of Functional Cytokines Displayed on Phages. In: Hust, M., Lim, T. (eds) Phage Display. Methods in Molecular Biology, vol 1701. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7447-4_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7447-4_30

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7446-7

  • Online ISBN: 978-1-4939-7447-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics